Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 18S ribosomal RNA 1
- Acanthamoeba 1
- Adolescent 2
- Adult 6
- Aedes 1
- Aged 4
- Aged, 80 and over 1
- Alphavirus Infections 1
- Amebiasis 1
- Americas 1
- Animals 3
- Anti-Bacterial Agents 1
- Antibodies, Monoclonal, Murine-Derived 1
- Antimicrobial Resistance 1
- Antineoplastic Agents 1
- Antitubercular Agents 2
- Artesunate 1
- Article 2
- Asia 1
- Bacteremia 1
- Bacteria 1
- Bedaquiline 1
- Bites and Stings 1
- Bordetella 1
- Bordetella Infections 1
- Burkholderia Pseudomallei 1
- Caribbean Region 1
- Carrier State 1
- Cellulitis 1
- Child 1
- Child, Preschool 1
- Communicable Diseases, Emerging 1
- Cross-Sectional Studies 1
- Delayed-Onset 1
- Delayed-Onset Hemolytic Anemia In Patients With Travel-Associated Severe Malaria Treated With Artesunate, France, 2011–2013 1
- Dermatitis 1
- Diagnosis, Differential 1
- Diarrhea 1
- Diarylquinolines 1
- Disease Outbreaks 1
- Dispatch 3
- DNA, Ribosomal 1
- Drug Resistance, Bacterial 1
- Drug Therapy, Combination 2
- Epidemics 1
- Extensively Drug-Resistant Tuberculosis 2
- Extensively Drug Resistant 1
- Fatal Outcome 1
- Female 5
- France 2
- GeoSentinel 2
- Guillain-Barre syndrome 1
- Guinea 1
- Heart Transplantation 1
- Heart transplantation 1
- Hemolysis 1
- Hemolytic Anemia 1
- Hemorrhagic Fever, Ebola 1
- Humans 11
- Immunocompromised Host 1
- Imported 1
- Incidence 2
- Individual Patient Data 1
- Infant 1
- Influenza, Human 1
- Insect Vectors 1
- Internationality 1
- International travel 1
- Leukemia, Hairy Cell 1
- Life Cycle Stages 1
- Linezolid 1
- Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France 1
- Lymphoma, Large B-Cell, Diffuse 1
- Maintenance Chemotherapy 1
- Malaria 3
- Malaria, Falciparum 1
- Male 7
- Mass gatherings 1
- Mdr 1
- MDR TB 1
- Melioidosis 1
- Middle Aged 4
- Mites 1
- Molecular Sequence Data 1
- Multidrug Resistant 1
- Mycobacterium Tuberculosis 1
- Mycobacterium tuberculosis 1
- Nose 1
- Outcome 1
- Outcomes Of Bedaquiline Treatment In Patients With Multidrug-Resistant Tuberculosis 1
- Oylmpics 1
- Parasites 1
- Plasmodium 1
- Plasmodium Falciparum 1
- Plasmodium spp 1
- Pregnancy 2
- Research 5
- Travel 6
- Tuberculosis 2
- Young Adult 2
Personal Author
Corporate Author
Place as Subject
Resource Type General
- Journal Article 14
- Letter 1
Resource Type Specific
- Letter 1
Keywords
Select all docs (Max 200)
1 -
15 of 15 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 18S ribosomal RNA (1)
- Acanthamoeba (1)
- Adolescent (2)
- Adult (6)
- Aedes (1)
- Aged (4)
- Aged, 80 and over (1)
- Alphavirus Infections (1)
- Amebiasis (1)
- Americas (1)
- Animals (3)
- Anti-Bacterial Agents (1)
- Antibodies, Monoclonal, Murine-Derived (1)
- Antimicrobial Resistance (1)
- Antineoplastic Agents (1)
- Antitubercular Agents (2)
- Artesunate (1)
- Article (2)
- Asia (1)
- Bacteremia (1)
- Bacteria (1)
- Bedaquiline (1)
- Bites and Stings (1)
- Bordetella (1)
- Bordetella Infections (1)
- Burkholderia Pseudomallei (1)
- Caribbean Region (1)
- Carrier State (1)
- Cellulitis (1)
- Child (1)
- Child, Preschool (1)
- Communicable Diseases, Emerging (1)
- Cross-Sectional Studies (1)
- Delayed-Onset (1)
- Delayed-Onset Hemolytic Anemia In Patients With Travel-Associated Severe Malaria Treated With Artesunate, France, 2011–2013 (1)
- Dermatitis (1)
- Diagnosis, Differential (1)
- Diarrhea (1)
- Diarylquinolines (1)
- Disease Outbreaks (1)
- Dispatch (3)
- DNA, Ribosomal (1)
- Drug Resistance, Bacterial (1)
- Drug Therapy, Combination (2)
- Epidemics (1)
- Extensively Drug-Resistant Tuberculosis (2)
- Extensively Drug Resistant (1)
- Fatal Outcome (1)
- Female (5)
- France (2)
- GeoSentinel (2)
- Guillain-Barre syndrome (1)
- Guinea (1)
- Heart Transplantation (1)
- Heart transplantation (1)
- Hemolysis (1)
- Hemolytic Anemia (1)
- Hemorrhagic Fever, Ebola (1)
- Humans (11)
- Immunocompromised Host (1)
- Imported (1)
- Incidence (2)
- Individual Patient Data (1)
- Infant (1)
- Influenza, Human (1)
- Insect Vectors (1)
- Internationality (1)
- International travel (1)
- Leukemia, Hairy Cell (1)
- Life Cycle Stages (1)
- Linezolid (1)
- Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France (1)
- Lymphoma, Large B-Cell, Diffuse (1)
- Maintenance Chemotherapy (1)
- Malaria (3)
- Malaria, Falciparum (1)
- Male (7)
- Mass gatherings (1)
- Mdr (1)
- MDR TB (1)
- Melioidosis (1)
- Middle Aged (4)
- Mites (1)
- Molecular Sequence Data (1)
- Multidrug Resistant (1)
- Mycobacterium Tuberculosis (1)
- Mycobacterium tuberculosis (1)
- Nose (1)
- Outcome (1)
- Outcomes Of Bedaquiline Treatment In Patients With Multidrug-Resistant Tuberculosis (1)
- Oylmpics (1)
- Parasites (1)
- Plasmodium (1)
- Plasmodium Falciparum (1)
- Plasmodium spp (1)
- Pregnancy (2)
- Research (5)
- Travel (6)
- Tuberculosis (2)
- Young Adult (2)
- :Angelo, Kristina M. ;Libman, MichaelJul 20 2017 | Malar J. 16.:BackgroundMore than 30,000 malaria cases are reported annually among international travellers. Despite improvements in malaria control, malaria contin...
- :Gautret, Philippe ;Angelo, Kristina M.2019 | Travel Med Infect Dis. 32:101504:BackgroundTravelers to international mass gatherings may be exposed to conditions which increase their risk of acquiring infectious diseases. Most exi...
- :Jaspard, Marie ;Elefant-Amoura, ElisabethOct 17 2017 | Emerg Infect Dis. 23(10):1731-1732.:A woman with extremely drug-resistant tuberculosis treated with a drug regimen including linezolid and bedaquiline during her last 3 weeks of pregnanc...
- :Jauréguiberry, Stéphane ;Thellier, MarcMay 2015 | Emerg Infect Dis. 21(5):804-812.:Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in ≈20% of travelers who re...
- :Mbuagbaw, Lawrence ;Guglielmetti, LorenzoMay 2019 | Emerg Infect Dis. 25(5):936-943:Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberc...
- :Del Giudice, Pascal ;Blanc-Amrane, VéroniqueNov 2008 | Emerg Infect Dis. 14(11):1759-1761:We investigated 42 patients who had unusual pruritic dermatitis associated with a specific clinical sign (comet sign) in 23 houses in southeastern Fra...
- :Jensenius, Mogens ;Davis, XiaohongNov 2009 | Emerg Infect Dis. 15(11):1791-1798.:We investigated epidemiologic and clinical aspects of rickettsial diseases in 280 international travelers reported to the GeoSentinel surveillance Net...
- :Barete, Stéphane ;Combes, AlainMay 2007 | Emerg Infect Dis. 13(5):736-738.:We report a fatal case of disseminated acanthamebiasis caused by Acanthamoeba lenticulata (genotype T5) in a 39-year-old heart transplant recipient. T...
- :Boggild, Andrea K. ;Esposito, Douglas H.6 2 2015 | Ann Intern Med. 162(11):757-764:BackgroundThe largest-ever outbreak of Ebola virus disease (EVD), ongoing in West Africa since late 2013, has led to export of cases to Europe and Nor...
- :Rossi, Benjamin ;Epelboin, LoïcMar 2013 | Emerg Infect Dis. 19(3):503-505.
- :Jaspard, Marie ;Butel, NathalieAug 2020 | Emerg Infect Dis. 26(8):1792-1800:Linezolid is one of the most effective drugs for treating multidrug-resistant tuberculosis (MDR TB), but adverse effects remain problematic. We evalua...
- :Hochedez, Patrick ;Jaureguiberry, StephaneOct 2006 | Emerg Infect Dis. 12(10):1565-1567.:The largest described outbreak of chikungunya virus has been occurring on the islands of the southwest Indian Ocean since March 2005. We describe the ...
- :Nguyen, Liem Binh Luong ;Epelboin, LoïcOct 2013 | Emerg Infect Dis. 19(10):1703-1705.
- :Eimer, Johannes ;Patimeteeporn, Calvin8 27 2021 | J Travel Med. 28(6):Background:Early detection of imported multidrug-resistant tuberculosis (MDR-TB) is crucial, but knowledge gaps remain about migration- and travel-ass...
- :Angelo, Kristina M. ;Stoney, Rhett J.7 14 2020 | J Travel Med. 27(4):Introduction:International travellers contribute to the rapid spread of Zika virus (ZIKV) and its sentinel identification globally. We describe ZIKV i...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.